Artículos de revistas
Expression And Activity Of Thimet Oligopeptidase (top) Are Modified In The Hippocampus Of Subjects With Temporal Lobe Epilepsy (tle)
Registro en:
Epilepsia. Blackwell Publishing Inc., v. 55, n. 5, p. 754 - 762, 2014.
139580
10.1111/epi.12606
2-s2.0-84901325507
Autor
Simoes P.S.R.
Visniauskas B.
Perosa S.R.
Yacubian E.M.T.
Centeno R.
Canzian M.
Lopes-Cendes I.
Maurer Morelli C.V.
Carrete Jr. H.
Cavalheiro E.A.
Tufik S.
Chagas J.R.
Naffah Mazzacoratti M.D.G.
Institución
Resumen
Objective Thimet oligopeptidase (TOP) is a metalloprotease that has been associated with peptide processing in several nervous system structures, and its substrates include several peptides such as bradykinin, amyloid beta (Aβ), and major histocompatibility complex (MHC) class I molecules. As shown previously by our research group, patients with temporal lobe epilepsy (TLE) have a high level of kinin receptors as well as kallikrein, a kinin-releasing enzyme, in the hippocampus. Methods In this study, we evaluated the expression, distribution, and activity of TOP in the hippocampus of patients with TLE and autopsy-control tissues, through reverse-transcription polymerase chain reaction (RT-PCR), enzymatic activity, Western blot, and immunohistochemistry. In addition, hippocampi of rats were analyzed using the pilocarpine-induced epilepsy model. Animals were grouped according to the epilepsy phases defined in the model as acute, silent, and chronic. Results Increased TOP mRNA expression, decreased protein levels and enzymatic activity were observed in tissues of patients, compared to control samples. In addition, decreased TOP distribution was also visualized by immunohistochemistry. Similar results were observed in tissues of rats during the acute phase of epilepsy model. However, increased TOP mRNA expression and no changes in immunoreactivity were found in the silent phase, whereas increased TOP mRNA expression and increased enzymatic activity were observed in the chronic phase. Significance The results show that these alterations could be related to a failure in the mechanisms involved in clearance of inflammatory peptides in the hippocampus, suggesting an accumulation of potentially harmful substances in nervous tissue such as Aβ, bradykinin, and antigenic peptides. These accumulations could be related to hippocampal inflammation observed in TLE subjects. © Wiley Periodicals, Inc. © 2014 International League Against Epilepsy. 55 5 754 762 Babb, T.L., Lieb, J.P., Brown, W.J., Synaptic reorganization by mossy fibers in human hippocampal formation (1984) Epilepsia, 25, pp. 721-728 De Lanerolle, N.C., Lee, T.S., New facets of neuropathology and molecular profile of human temporal lobe epilepsy (2005) Epilepsy Behav, 7, pp. 190-203 Shrimpton, C.N., Smith, A.L., Soluble neutral metallopeptidase: Physiological regulators of peptides action (2000) J Pept Sci, 6, pp. 251-263 Yamin, R., Malgeri, E.G., Sloane, J.A., Metalloendopeptidase EC 3.4.24.15 is necessary for Alzheimer's amyloid-β peptide degradation (1999) J Biol Chem, 274, pp. 18777-18784 Pollio, G., Hoozemans, J.J., Andersen, C.A., Increased expression of the oligopeptidase THOP1 is a neuroprotective response to βa toxicity (2008) Neurobiol Dis, 31, pp. 145-158 Cuevas, M.E., Haensgen, H., Sepúlveda, F.J., Soluble Aβ (1-40) peptide increase excitatory neurotransmission and induces epileptiform activity in hippocampal neurons (2011) J Alzheimers Dis, 23, pp. 673-687 Portaro, F.C., Gomes, M.D., Cabrera, A., Thimet oligopeptidase and the stability of MHC class i epitopes in macrophage cytosol (1999) Biochem Biophys Res Commun, 255, pp. 596-601 Silva, C.L., Portaro, F.C.V., Bonato, V.L.D., Thimet oligopeptidase (EC 3.4.24.15), a novel protein on the route of MHC class i antigen presentation (1999) Biochem Biophys Res Commun, 255, pp. 591-595 Saric, T., Beninga, J., Graef, C.I., Major histocompatibility complex class I-presented antigenic peptides are degraded in cytosolic extracts primarily by thimet oligopeptidase (2001) J Biol Chem, 276, pp. 36474-36481 Kim, S.I., Pabon, A., Swanson, T.A., Regulation of cell-surface major histocompatibility complex class i expression by the endopeptidase EC3.4.24.15 (thimet oligopeptidase) (2003) Biochem J, 375, pp. 111-120 York, I.A., Mo, A.X., Lemerise, K., The cytosolic endopeptidase, thimet oligopeptidase, destroys antigenic peptides and limits the extent of MHC class i antigen presentation (2003) Immunity, 18, pp. 429-440 Shrimpton, C.N., Smith, A.I., Lew, R.A., Soluble metallopeptidases and neuroendocrine signaling (2002) Endocr Rev, 23, pp. 647-664 Norman, M.U., Lew, R.A., Smith, A.I., Metalloendopeptidases EC 3.4.24.15/16 regulate bradykinin activity in the cerebral microvasculature (2003) Am J Physiol Heart Circ Physiol, 284, pp. 1942-1948 Perosa, S.R., Argañaraz, G.A., Goto, E.M., Kinin B1 and B2 receptors are overexpressed in the hippocampus of humans with temporal lobe epilepsy (2007) Hippocampus, 17, pp. 26-33 Argañaraz, G.A., Silva, Jr.J.A., Perosa, S.R., The synthesis and distribution of the kinin B1 and B2 receptors are modified in the hippocampus of rats submitted to pilocarpine model of epilepsy (2004) Brain Res, 23, pp. 114-125 Simões, P.S., Perosa, S.R., Argañaraz, G.A., Kallikrein 1 is overexpressed by astrocytes in the hippocampus of patients with refractory temporal lobe epilepsy, associated with hippocampal sclerosis (2011) Neurochem Int, 4, pp. 477-482 Argañaraz, G.A., Perosa, S.R., Lencioni, E.C., Role of kinin B1 and B2 receptors in the development of pilocarpine model of epilepsy (2004) Brain Res, 210, pp. 30-39 Kläsner, B., Lumenta, D.B., Pruneau, D., Therapeutic window of bradykinin B2 receptor inhibition after focal cerebral ischemia in rats (2006) Neurochem Int, 49, pp. 442-447 Turski, W.A., Cavalheiro, E.A., Schwarz, M., Limbic seizures produced by pilocarpine in rats: Behavioral, electroencehalographic and neuropathological study (1983) Behav Brain Res, 9, pp. 315-335 Leite, J.P., Bortolotto, Z.A., Cavalheiro, E.A., Spontaneous recurrent seizures in rats: An experimental model of partial epilepsy (1990) Neurosci Biobehav Rev, 14, pp. 511-517 Lowry, O.H., Rosebrough, N.J., Farr, A.L., Protein measurement with the Folin phenol reagent (1951) J Biol Chem, 193, pp. 265-275 Oliveira, V., Campos, M., Melo, R.L., Substrate specificity characterization of recombinant metallo oligopeptidase and neurolysin (2001) Biochemistry, 40, pp. 4417-4425 Acker, G.R., Molineaux, C., Orlowski, M., Synaptosomal membrane-bound form of endopeptidase 24.15 generates Leu-enkephalin from dynorphin 1-8, alpha and beta-neoendorphin, and met-enkephalin from met-enkephalin-Arg6 - Gly7-Leu8 (1987) J Neurochem, 48, pp. 284-292 Vezzani, A., Granata, T., Brain inflammation in epilepsy: Experimental and clinical evidence (2005) Epilepsia, 46, pp. 1724-1743